-
www.uspreventiveservicestaskforce.org/uspstf/document/draft-research-plan/tobacco-smoking-cessation-in-adults-including-pregnant-women-interventions
March 15, 2018 - in progress
Draft Research Plan
Interventions for Tobacco Smoking Cessation in Adults, Including Pregnant Persons
March 15, 2018
Recommendations made by the USPSTF are independent of the U.S. government. They should not be construed as an official position of the Agency for Healthcare Research and Quality or the U.…
-
www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan/prevention-of-human-immunodeficiency-virus-hiv-infection-pre-exposure-prophylaxis-june-2019
July 26, 2017 - Share to Facebook
Share to X
Share to WhatsApp
Share to Email
Print
archived
Final Research Plan
Prevention of Human Immunodeficiency Virus (HIV) Infection: Preexposure Prophylaxis
July 26, 2017
Recommendations made by the USPSTF are indep…
-
www.uspreventiveservicestaskforce.org/uspstf/recommendation/depression-in-children-and-adolescents-screening-2009
March 15, 2009 - comorbid mental health or chronic medical conditions, and having experienced a major negative life event … comorbid mental health or chronic medical conditions, and having experienced a major negative life event
-
www.uspreventiveservicestaskforce.org/uspstf/recommendation/osteoporosis-screening-june-2018
June 26, 2018 - Share to Facebook
Share to X
Share to WhatsApp
Share to Email
Print
archived
Final Recommendation Statement
Osteoporosis to Prevent Fractures: Screening
June 26, 2018
Recommendations made by the USPSTF are independent of the U.S. gover…
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/4KRE4cPgK7ePRf9oq28vTd
October 11, 2022 - Comparable intensity of therapy in study groups, coupled
with low event rates for some outcomes (such
-
www.uspreventiveservicestaskforce.org/uspstf/announcements/us-preventive-services-task-force-issues-final-evidence-report-screening-coronary-heart-disease-electrocardiography
September 21, 2011 - U.S. Preventive Services Task Force Issues Final Evidence Report for Screening for Coronary Heart Disease With Electrocardiography
Share to Facebook
Share to X
Share to WhatsApp
Share to Email
Print
September 21, 2011 – In order to update its…
-
www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary1/osteoporosis-screening
June 26, 2018 - Share to Facebook
Share to X
Share to WhatsApp
Share to Email
Print
Evidence Summary
Osteoporosis to Prevent Fractures: Screening
June 26, 2018
Recommendations made by the USPSTF are independent of the U.S. government. They should not be con…
-
www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary1/osteoporosis-screening-june-2018
June 26, 2018 - Share to Facebook
Share to X
Share to WhatsApp
Share to Email
Print
archived
Evidence Summary
Osteoporosis to Prevent Fractures: Screening
June 26, 2018
Recommendations made by the USPSTF are independent of the U.S. government. They should…
-
www.uspreventiveservicestaskforce.org/uspstf/recommendation/peripheral-arterial-disease-pad-screening
August 08, 2005 - archived
Final Recommendation Statement
Peripheral Arterial Disease (PAD): Screening
August 08, 2005
Recommendations made by the USPSTF are independent of the U.S. government. They should not be construed as an official position of the Agency for Healthcare Research and Quality or the U.S. Departme…
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/a_x9VThjBWewPwLWsUkVav
January 01, 2015 - no difference between treatment with
vitamin D and placebo or no treatment in risk for any
adverse event
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/_SBmXPhUQWo-dc85FJ5wHf
February 01, 2015 - Diagnostic and Predictive Accuracy of Blood Pressure Screening
Methods With Consideration of Rescreening Intervals: A Systematic
Review for the U.S. Preventive Services Task Force
Margaret A. Piper, PhD, MPH; Corinne V. Evans, MPP; Brittany U. Burda, MPH; Karen L. Margolis, MD, MPH;
Elizabeth O’Connor, PhD; and Evelyn …
-
www.uspreventiveservicestaskforce.org/uspstf/draft-recommendation/glaucoma-screening-adults-older-adults
October 26, 2021 - due to adverse events (RR, 2.40, [95% CI, 0.71 to 19.32]; I 2 =0%; 5 trials; n=648), or any adverse event
-
www.uspreventiveservicestaskforce.org/uspstf/draft-recommendation/primary-angle-glaucoma-screening
October 26, 2021 - due to adverse events (RR, 2.40, [95% CI, 0.71 to 19.32]; I 2 =0%; 5 trials; n=648), or any adverse event
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/9AtjNaSwTXonz49w_DEbNz
November 07, 2023 - re-
ported 12 of 1473 children assigned to varnish reported adverse
events (the most common adverse event … events and 1 trial reported 0.04% of
children allocated to varnish
reported a self-limited adverse
event
-
www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary/breast-cancer-screening
April 30, 2024 - Twenty-seven participants (0.6% of the MRI group) reported a serious adverse event within 30 days of
-
www.uspreventiveservicestaskforce.org/uspstf/document/draft-research-plan/colorectal-cancer-screening3
January 03, 2019 - in progress
Draft Research Plan
Screening for Colorectal Cancer
January 03, 2019
Recommendations made by the USPSTF are independent of the U.S. government. They should not be construed as an official position of the Agency for Healthcare Research and Quality or the U.S. Department of Health and Human Se…
-
www.uspreventiveservicestaskforce.org/uspstf/document/routine-vitamin-supplementation-to-prevent-cancer-update-of-the-evidence-from-randomized-controlled-trials-19992002/vitamin-supplementation-to-prevent-cancer-and-cvd-counseling-and-preventive-medication-2003
June 15, 2003 - Share to Facebook
Share to X
Share to WhatsApp
Share to Email
Print
archived
Routine Vitamin Supplementation to Prevent Cancer: Update of the Evidence from Randomized Controlled Trials 1999-2002*
Vitamin Supplementation to Prevent Cancer and CVD: C…
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/boPWHmzrtxnkkPQAoCNENS
September 18, 2018 - For harms, RCTs, systematic reviews, and large cohort,
case-control, or event-monitoring studies were … Safety profile
of orlistat: results of a prescription-event
monitoring study.
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/WEqCV3NvnZAeLdC_pp6nVK
October 01, 2018 - Supplement).13,14,16,17 DAA regi-
mens were associated with slightly increased risk of any adverse
event … Pooled Adverse Event Rates for DAA Regimens | DAA therapy was fre-
quently associated with experiencing … any adverse event (44 trials,
n = 8045; 73.3% [95% CI, 68.0% to 78.1%]; I2 = 95%) (eFigure 4
in the … Adverse event estimates were generally similar when
studies were stratified according to baseline cirrhosis … HCV genotypes, low rates of serious adverse
events and treatment discontinuation, and higher adverse event
-
www.uspreventiveservicestaskforce.org/uspstf/draft-recommendation/prediabetes-and-type-2-diabetes-mellitus-screening
March 16, 2021 - risk of all-cause mortality, cardiovascular-related mortality, occurrence of a first cardiovascular event